Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla.Feb. 7, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and Europe—while continuing to bring Sensus’ innovative SRT treatment to patients all over the world who are afflicted with both non-melanoma skin cancers and keloids.

Read the full press release here.

Share to:

Contact Us

Fill out the form below to find out more!